Gene · 3588
Papers2,588
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,588
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CLEC11A expression as a prognostic biomarker in correlation to immune cells of gastric cancer. | Biomol Biomed | 2024 | 37597212 | PubTator, text mining | PubMed |
| Clinical and cellular phenotypes resulting from a founder mutation in IL10RB. | Clin Exp Immunol | 2024 | 37503744 | PubTator, text mining | PubMed |
| Role of interferons in the antiviral battle: from virus-host crosstalk to prophylactic and therapeutic potential in SARS-CoV-2 infection. | Front Immunol | 2023 | 38288121 | PubTator, text mining | PubMed |
| The causal effect of cytokine cycling levels on osteoarthritis: a bidirectional Mendelian randomized study. | Front Immunol | 2023 | 38274820 | PubTator, text mining | PubMed |
| Peripheral immune responses to filoviruses in a reservoir versus spillover hosts reveal transcriptional correlates of disease. | Front Immunol | 2023 | 38259437 | PubTator, text mining | PubMed |
| Early inflammatory markers as prognostic indicators following allogeneic stem cell transplantation. | Front Immunol | 2023 | 38235129 | PubTator, text mining | PubMed |
| The Immune Signature of CSF in Multiple Sclerosis with and without Oligoclonal Bands: A Machine Learning Approach to Proximity Extension Assay Analysis. | Int J Mol Sci | 2023 | 38203309 | PubTator, text mining | PubMed |
| Sox10-Deficient Drug-Resistant Melanoma Cells Are Refractory to Oncolytic RNA Viruses. | Cells | 2023 | 38201278 | PubTator, text mining | PubMed |
| Antioxidant mechanisms of mesenchymal stem cells and their therapeutic potential in vitiligo. | Front Cell Dev Biol | 2023 | 38178870 | PubTator, text mining | PubMed |
| One-month assessment of Th-cell axis related inflammatory cytokines, IL-17 and IL-22 and their role in alcohol-associated liver disease. | Front Immunol | 2023 | 38162671 | PubTator, text mining | PubMed |
| The Influence of Metabolism on Immune Response: A Journey to Understand Immunometabolism in the Context of Viral Infection. | Viruses | 2023 | 38140640 | PubTator, text mining | PubMed |
| Cell Intrinsic Determinants of Alpha Herpesvirus Latency and Pathogenesis in the Nervous System. | Viruses | 2023 | 38140525 | PubTator, text mining | PubMed |
| Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions. | Molecules | 2023 | 38138551 | PubTator, text mining | PubMed |
| A Narrative Review of Cytokine Networks: Pathophysiological and Therapeutic Implications for Inflammatory Bowel Disease Pathogenesis. | Biomedicines | 2023 | 38137450 | PubTator, text mining | PubMed |
| Identification and characterization of the anti-viral interferon lambda 3 as direct target of the Epstein-Barr virus microRNA-BART7-3p. | Oncoimmunology | 2023 | 38126030 | PubTator, text mining | PubMed |
| Molecular and immunological characteristics of patients with CMTM6 low expression colorectal cancer. | Medicine (Baltimore) | 2023 | 38115316 | PubTator, text mining | PubMed |
| Systematic analysis based on the cuproptosis-related genes identifies ferredoxin 1 as an immune regulator and therapeutic target for glioblastoma. | BMC Cancer | 2023 | 38114959 | PubTator, text mining | PubMed |
| A peptide derived from interleukin-10 exhibits potential anticancer activity and can facilitate cell targeting of gold nanoparticles loaded with anticancer therapeutics. | Commun Chem | 2023 | 38102207 | PubTator, text mining | PubMed |
| Early human lung immune cell development and its role in epithelial cell fate. | Sci Immunol | 2023 | 38100545 | PubTator, text mining | PubMed |
| Transcriptome research of human amniocytes identifies hub genes associated with developmental dysplasia in down syndrome. | Aging (Albany NY) | 2023 | 38095646 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3588/papers?page=8